Overproduced p73α activates a minimal promoter through a mechanism independent of its transcriptional activity

被引:6
作者
Takagi, S [1 ]
Ueda, Y [1 ]
Hijikata, M [1 ]
Shimotohno, K [1 ]
机构
[1] Kyoto Univ, Inst Virus Res, Dept Viral Oncol, Sakyo Ku, Kyoto 6068507, Japan
关键词
p73; splicing variant; transcription; p53;
D O I
10.1016/S0014-5793(01)03141-6
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
p73, the gene for a protein related to the tumor suppressor p53, encodes several variants which bear distinct carboxy-terminal structures as a result of alternative splicing. We and others showed that these splicing variants have different transcriptional effects on promoters with a p53-binding consensus sequence (p53BCS). Here we show that when transiently overexpressed, p73 alpha but not p73 beta activated several minimal promoters without the p53BCS, while p73 gamma and p73 epsilon activated them to a much lesser extent than p73 alpha, and p53 suppressed the promoters without p53BCS as reported previously. Moreover, the results of RNase protection and RNA transfection assays suggested that this activation occurred at the transcriptional level. Deletion analysis of p73 alpha revealed that the transactivation domain of p73 was not involved in this activity and the C-terminal region of p73 alpha which is a specific structure of this variant was essential, suggesting that this phenomenon occurs independent of the transactivation activity of p73 alpha and that the C-terminal extension of p73 alpha may affect the basal level of transcription. (C) 2001 Published by Elsevier Science B.V. on behalf of the Federation of European Biochemical Societies.
引用
收藏
页码:47 / 52
页数:6
相关论文
共 37 条
[1]  
Agami R, 1999, NATURE, V399, P809
[2]   REGULATION OF THE HUMAN HSP70 PROMOTER BY P53 [J].
AGOFF, SN ;
HOU, J ;
LINZER, DIH ;
WU, B .
SCIENCE, 1993, 259 (5091) :84-87
[3]   HTLV-1 Tax oncoprotein represses the p53-mediated trans-activation function through coactivator CBP sequestration [J].
Ariumi, Y ;
Kaida, A ;
Lin, JY ;
Hirota, M ;
Masui, O ;
Yamaoka, S ;
Taya, Y ;
Shimotohno, K .
ONCOGENE, 2000, 19 (12) :1491-1499
[4]  
BARDI G, 1993, CANCER RES, V53, P1895
[5]   Solution structure of a conserved C-terminal domain of p73 with structural homology to the SAM domain [J].
Chi, SW ;
Ayed, A ;
Arrowsmith, CH .
EMBO JOURNAL, 1999, 18 (16) :4438-4445
[6]   MODULATION OF ACTIVITY OF THE PROMOTER OF THE HUMAN MDR1 GENE BY RAS AND P53 [J].
CHIN, KV ;
UEDA, K ;
PASTAN, I ;
GOTTESMAN, MM .
SCIENCE, 1992, 255 (5043) :459-462
[7]   p73 and p63 are homotetramers capable of weak heterotypic interactions with each other but not with p53 [J].
Davison, TS ;
Vagner, C ;
Kaghad, M ;
Ayed, A ;
Caput, D ;
Arrowsmith, CH .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (26) :18709-18714
[8]   Two new p73 splice variants, γ and δ, with different transcriptional activity [J].
De Laurenzi, V ;
Costanzo, A ;
Barcaroli, D ;
Terrinoni, A ;
Falco, M ;
Annicchiarico-Petruzzeli, M ;
Levrero, M ;
Melino, G .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (09) :1763-1768
[9]  
Deb D, 2001, INT J ONCOL, V18, P401
[10]  
Di Como CJ, 1999, MOL CELL BIOL, V19, P1438